- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
EDAP TMS S.A.(FOCL)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for FOCL
11/13/2026: FOCL (1-star) is currently NOT-A-BUY. Pass it for now.
EDAP TMS S.A. is a medical technology company specializing in robotic high-intensity focused ultrasound systems for non-invasive urological care. The company's primary strength is its flagship Focal One platform, which benefits from rising clinical adoption and a growing base of recurring revenue streams. Its core growth opportunity lies in expanding procedural adoption and advancing clinical trials into new indications like BPH and endometriosis. However, the company faces ongoing financial and execution risks, including persistent net operating losses and intense competition from much larger medical device conglomerates. This stock is best suited for growth-oriented investors willing to monitor hospital adoption rates and regulatory progress closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | EDAP offers direct exposure to expanding robotic healthcare adoption and rapid top-line scaling in focal ultrasound technology. |
| Momentum investor | Strong fit while signal remains positive | The stock frequently reacts strongly to clinical data readouts, regulatory approvals, and quarterly sales milestones. |
| Value investor | Weak fit | The company currently lacks consistent profitability and positive net income, trading primarily on future growth prospects. |
| Dividend investor | Weak fit | EDAP does not pay dividends, retaining all earnings to fund commercialization and R&D. |
| Low-risk investor | Weak fit | Small-cap clinical-stage or early-commercial medical device equities carry high regulatory, execution, and financial volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Small-cap biotechnology and medical device stocks experience sharp price fluctuations based on sentiment and news flow. |
| Valuation risk | Medium / high | Valuation relies heavily on long-term multi-year revenue projections rather than near-term earnings or cash flow. |
| Competition risk (robotics and alternative therapies) | High | The company competes with entrenched medical device giants possessing vastly superior capital and distribution networks. |
| Business quality | Medium | Proprietary medical technology provides a defensive moat, though lack of net profitability limits immediate financial quality scores. |
| Dividend income | Low / none | No dividend distributions are paid to shareholders. |
| Execution risk | High | Success depends entirely on hospital adoption rates, physician training, and expanding reimbursement for Focal One. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 153.23M USD | Price to earnings Ratio - | 1Y Target Price 8.3 |
Price to earnings Ratio - | 1Y Target Price 8.3 | ||
Volume (30-day avg) 59.2K shares | Beta -0.02 | 52 Weeks Range 1.95 - 6.40 | Updated Date 11/15/2026 |
52 Weeks Range 1.95 - 6.40 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.35 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Distribution
- BUY participation
- 100.0%
- Active BUY / eligible
- 3 / 3
- 30-Day BUY Count Change
- +2
Eligible universe: 3 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 8.06% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| HIFU Systems & Treatments | Sales and operating leases of Focal One robotic units, treatment fees, and related single-use disposables. | This is the core engine driving future growth and high-margin recurring streams. |
| HIFU Maintenance Services | Annual service contracts and technical support for installed Focal One systems. | Provides predictable, recurring maintenance revenue as the global install base grows. |
| ESWL & Distribution Services | Legacy lithotripsy parts and distribution of third-party medical lasers and micro-ultrasound systems. | Serves as a secondary revenue contributor while the company transitions fully to its focal therapy focus. |
| Geographic Exposure (US & International) | Commercial operations spanning the United States, Europe, and international markets via direct sales and local partners. | U.S. hospital expansion and reimbursement trends dictate overall revenue acceleration. |
Valuation
Trailing PE - | Forward PE 38.91 | Enterprise Value 134.79M | Price to Sales(TTM) 1.88 |
Enterprise Value 134.79M | Price to Sales(TTM) 1.88 | ||
Enterprise Value to Revenue 1.66 | Enterprise Value to EBITDA 1165.78 | Shares Outstanding 47.22M | Shares Floating 34.07M |
Shares Outstanding 47.22M | Shares Floating 34.07M | ||
Percent Insiders 5.38 | Percent Institutions 40.32 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

